6,741
Views
31
CrossRef citations to date
0
Altmetric
Articles

Long-term follow-up of Helicobacter pylori reinfection and its risk factors after initial eradication: a large-scale multicentre, prospective open cohort, observational study

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & show all
Pages 548-557 | Received 25 Nov 2019, Accepted 28 Feb 2020, Published online: 11 Mar 2020

References

  • Ailloud F, Didelot X, Woltemate S, et al. Within-host evolution of Helicobacter pylori shaped by niche-specific adaptation, intragastric migrations and selective sweeps. Nat Commun. 2019;10(1):2273.
  • Sugano K, Tack J, Kuipers EJ, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64(9):1353–1367.
  • Leja M, Axon A, Brenner H. Epidemiology of Helicobacter pylori infection. Helicobacter. 2016;21(Suppl. 1):3–7.
  • Malaty HM, El-Kasabany A, Graham DY, et al. Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet. 2002;359(9310):931–935.
  • Crowe SE. Helicobacter pylori infection. N Engl J Med. 2019;380(12):1158–1165.
  • Tacconelli E, Carrara E, Savoldi A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318–327.
  • Harmati M, Gyukity-Sebestyen E, Dobra G, et al. Binary mixture of Satureja hortensis and Origanum vulgare subsp. hirtum essential oils: in vivo therapeutic efficiency against Helicobacter pylori infection. Helicobacter. 2017;22(2):e12350.
  • Wu JY, Lee YC, Graham DY. The eradication of Helicobacter pylori to prevent gastric cancer: a critical appraisal. Expert Rev Gastroenterol Hepatol. 2019;13(1):17–24.
  • Malfertheiner P, Megraud F, O’Morain CA, et al. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut. 2017;66(1):6–30.
  • O’Connor A, Lamarque D, Gisbert JP, et al. Treatment of Helicobacter pylori infection 2017. Helicobacter. 2017;22(Suppl. 1):e12410.
  • Corral JE, Mera R, Dye CW, et al. Helicobacter pylori recurrence after eradication in Latin America: Implications for gastric cancer prevention. World J Gastrointest Oncol. 2017;9(4):184–193.
  • Bohr UR, Malfertheiner P. Eradication of H. pylori infection: the challenge is on if standard therapy fails. Therap Adv Gastroenterol. 2009;2(1):59–66.
  • Gisbert JP. The recurrence of Helicobacter pylori infection: incidence and variables influencing it. A critical review. Am J Gastroenterol. 2005;100(9):2083–2099.
  • Shah E, Chey WD. Editorial: recurrence of Helicobacter pylori infection-still the same after all these years. Aliment Pharmacol Ther. 2018;47(1):131–132.
  • Moya DA, Crissinger KD. Helicobacter pylori persistence in children: distinguishing inadequate treatment, resistant organisms, and reinfection. Curr Gastroenterol Rep. 2012;14(3):236–242.
  • Zhang YY, Xia HH, Zhuang ZH, et al. Review article: ‘true’ re-infection of Helicobacter pylori after successful eradication–worldwide annual rates, risk factors and clinical implications. Aliment Pharmacol Ther. 2009;29(2):145–160.
  • Xia HX, Talley NJ, Keane CT, et al. Recurrence of Helicobacter pylori infection after successful eradication: nature and possible causes. Dig Dis Sci. 1997;42(9):1821–1834.
  • Bruce MG, Bruden DL, Morris JM, et al. Reinfection after successful eradication of Helicobacter pylori in three different populations in Alaska. Epidemiol Infect. 2015;143(6):1236–1246.
  • Mitchell HM, Hu P, Chi Y, et al. A low rate of reinfection following effective therapy against Helicobacter pylori in a developing nation (China). Gastroenterology. 1998;114(2):256–261.
  • Zhou LY, Song ZQ, Xue Y, et al. Recurrence of Helicobacter pylori infection and the affecting factors: a follow-up study. J Dig Dis. 2017;18(1):47–55.
  • Zhou LY, Lin SR, Shen ZY, et al. Five-year follow-up study after Helicobacter pylori eradication: reinfection and peptic ulcer status. Chin J Dig Dis. 2003;4(1):45–48.
  • Xue Y, Zhou LY, Lu HP, et al. Recurrence of Helicobacter pylori infection: incidence and influential factors. Chin Med J. 2019;132(7):765–771.
  • Suzuki H, Mori H. World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat. J Gastroenterol. 2018;53(3):354–361.
  • Kayali S, Manfredi M, Gaiani F, et al. Helicobacter pylori, transmission routes and recurrence of infection: State of the art. Acta Biomed. 2018;89:72–76.
  • Hu Y, Wan JH, Li XY, et al. Systematic review with meta-analysis: the global recurrence rate of Helicobacter pylori. Aliment Pharmacol Therap. 2017;46(9):773–779.
  • Megraud F, Lamouliatte H. Helicobacter pylori infection relapse after eradication is not a problem in developed countries. Nat Clin Pract Gastroenterol Hepatol. 2006;3(9):484–485.
  • Take S, Mizuno M, Ishiki K, et al. Reinfection rate of Helicobacter pylori after eradication treatment: a long-term prospective study in Japan. J Gastroenterol. 2012;47(6):641–646.
  • Yan TL, Hu QD, Zhang Q, et al. National rates of Helicobacter pylori recurrence are significantly and inversely correlated with human development index. Aliment Pharmacol Therap. 2013;37(10):963–968.
  • Bamford KB, Bickley J, Collins JS, et al. Helicobacter pylori: comparison of DNA fingerprints provides evidence for intrafamilial infection. Gut. 1993;34(10):1348–1350.
  • Peitz U, Hackelsberger A, Malfertheiner P. A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapy. Drugs. 1999;57(6):905–920.
  • Okimoto T, Murakami K, Sato R, et al. Is the recurrence of Helicobacter pylori infection after eradication therapy resultant from recrudescence or reinfection, in Japan. Helicobacter. 2003;8(3):186–191.
  • Kim SY, Hyun JJ, Jung SW, et al. Helicobacter pylori recurrence after first- and second-line eradication therapy in Korea: the problem of recrudescence or reinfection. Helicobacter. 2014;19(3):202–206.
  • Raymond J, Thiberge JM, Dauga C. Diagnosis of Helicobacter pylori recurrence: relapse or reinfection? Usefulness of molecular tools. Scand J Gastroenterol. 2016;51(6):672–678.
  • Kim MS, Kim N, Kim SE, et al. Long-term follow-up Helicobacter pylori reinfection rate and its associated factors in Korea. Helicobacter. 2013;18(2):135–142.
  • Abu-Mahfouz MZ, Prasad VM, Santogade P, et al. Helicobacter pylori recurrence after successful eradication: 5-year follow-up in the United States. Am J Gastroenterol. 1997;92(11):2025–2028.
  • Borody TJ, Andrews P, Mancuso N, et al. Helicobacter pylori reinfection rate, in patients with cured duodenal ulcer. Am J Gastroenterol. 1994;89(4):529–532.
  • Gomez Rodriguez BJ, Rojas Feria M, Garcia Montes MJ, et al. Incidence and factors influencing on Helicobacter pylori infection recurrence. Rev Esp Enferm Dig. 2004;96(9):620–623; 424–627.
  • Shimizu T, Yarita Y, Kaneko K, et al. Case of intrafamilial Helicobacter pylori reinfection after successful eradication therapy. Pediatr Infect Dis J. 2000;19(9):901–903.
  • Nam JH, Ryu KH, Park BJ, et al. Rate and predictive factors of Helicobacter pylori recurrence: analysis of a screening cohort. Saudi J Gastroenterol. 2019;25(4):251–256.
  • Gisbert JP, Arata IG, Boixeda D, et al. Role of partner’s infection in reinfection after Helicobacter pylori eradication. Eur J Gastroenterol Hepatol. 2002;14(8):865–871.
  • Tongtawee T, Wattanawongdon W, Simawaranon T. Effects of periodontal therapy on eradication and recurrence of Helicobacter pylori infection after successful treatment. J Int Med Res. 2019;47(2):875–883.
  • Karczewska E, Konturek JE, Konturek PC, et al. Oral cavity as a potential source of gastric reinfection by Helicobacter pylori. Dig Dis Sci. 2002;47(5):978–986.
  • Kilmartin CM. Dental implications of Helicobacter pylori. J Can Dent Assoc. 2002;68(8):489–493.
  • Sugiyama T, Naka H, Yachi A, et al. Direct evidence by DNA fingerprinting that endoscopic cross-infection of Helicobacter pylori is a cause of postendoscopic acute gastritis. J Clin Microbiol. 2000;38(6):2381–2382.